Clinical Trial Update: Colorectal Cancer (CRC) Cetuximab Elderly Frail [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cetuximab in elderly frail patients with metastatic colorectal cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: TERMINATED